Written and medically reviewed by: Assoc. Prof. Cengiz Dibekoğlu, MD, General SurgeryLast updated:
Gastrointestinal Stromal Tumor (GIST)
Gastrointestinal stromal tumors are sarcoma-biology lesions — KIT/PDGFRA context guides tyrosine-kinase therapy.
GISTs arise from interstitial cells of Cajal lineage and behave unlike ordinary adenocarcinomas. Pathology with KIT/DOG1 IHC and mutation testing (KIT/PDGFRA, including D842V resistance patterns) directs imatinib and later-line TKIs. Small gastric GISTs may be observed under strict criteria; larger or symptomatic lesions need resection with capsule care, not casual enucleation habits from other tumors. These tumors follow sarcoma or neuroendocrine rules, not generic adenocarcinoma pathways.
Educational schematic. Some structures may be simplified or emphasized for clarity; not an exact anatomical depiction.
© Cengiz Dibekoğlu — illustrative; not for unauthorized use
Figure summary
This educational figure shows: GIST.
Who may be a candidate?
- International patients preparing a structured second-opinion visit
- Patients comparing observation, medical care, and procedural options
Possible advantages
- Supports informed consent with alternatives and recovery themes
- Highlights red flags that should trigger urgent contact
Limits & realistic expectations
- Cannot replace examination, imaging, or pathology
- Local protocols and tumor-board decisions may refine timing
- Outcomes vary with anatomy, stage, and comorbidity
Step-by-step overview
- 1
Clarify the clinical question
What diagnosis is being confirmed and what decision follows?
- 2
Choose first-line tests
Start with the test that answers the leading question safely.
- 3
Stage if needed
Add imaging or endoscopy when results would change management.
- 4
Name limitations
No test replaces exam; false reassurance is a risk.
- 5
Link to next step
Diagnosis should point to observation, medical care, or procedure.
Key points
- Key note inside
Important
This page is for education. It is not medical advice and does not replace a visit with your physician.
Frequently asked questions
Is GIST the same as stomach adenocarcinoma?
No. GIST follows sarcoma biology with different drugs and surgical principles.
Why do KIT/PDGFRA mutations matter?
They guide tyrosine-kinase therapy and resistance patterns such as PDGFRA D842V.
Can small gastric GISTs be watched?
Selected tiny low-risk lesions may be observed under protocol — not all.
Is wide lymphadenectomy routine?
Usually more limited than adenocarcinoma pathways.
More chapters in this hub
Appointment / info
This page is for education. It is not medical advice and does not replace a visit with your physician.
Medical editor: Assoc. Prof. Cengiz Dibekoğlu, MD · Last medically reviewed: August 2026 · English patient-education chapter.